A carregar...
Activity of 129 Single-Agent Drugs in 228 Phase I and II Clinical Trials in Multiple Myeloma
BACKGROUND: More than 400 preclinical studies report ≥ 1 compound as cytotoxic to multiple myeloma (MM) cells; however, few of these agents became relevant in the clinic. Thus, the utility of such assays in predicting future clinical value is debatable. PATIENTS AND METHODS: We examined the applicat...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4092053/ https://ncbi.nlm.nih.gov/pubmed/24565465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2013.12.015 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|